Endava price target lowered to $55 from $60 at Guggenheim

Guggenheim analyst Jonathan Lee lowered the firm’s price target on Endava to $55 from $60 and keeps a Buy rating on the shares. The firm cites higher interest expense and integration costs for its lower target, but contends that implied flat organic growth in Q4 “marks signs of relative stabilization and progress.”